Ferris Capital’s Alterity Therapeutics ATHE Stock Holding History

Ferris Capital’s Portfolio ATHE Stock Details ATHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-33	Closed	-$1K	–	184
2017 Q2	$1K	Buy	+33	New	+$821	﹤0.01%	637

Other funds holding ATHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Landaas & Company Milwaukee, Wisconsin $550M AUM 22.32% 1-Year Est. Return

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

Ferris Capital's ATHE Position: Q3 2017 in Review

Ferris Capital sold out of Alterity Therapeutics (ATHE) in Q3 2017, closing a stake of 33 shares — an estimated $1K sold.

Ferris Capital first reported a position in ATHE in Q2 2017 and held it in 1 quarter. The position peaked at $1K in Q2 2017. 14 funds tracked by Wall St. Rank hold ATHE as of Q3 2017.

Ferris Capital reported no remaining Alterity Therapeutics position as of Q3 2017 after selling out during the quarter.
Ferris Capital sold 33 Alterity Therapeutics shares in Q3 2017, an estimated $1K.
Ferris Capital first reported a position in Alterity Therapeutics in Q2 2017 and held it in 1 quarter.
Ferris Capital's Alterity Therapeutics position peaked at $1K in Q2 2017.
14 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q3 2017.

Based on Ferris Capital's 13F filing for Q3 2017, filed 14 Nov 2017.